Global measles resurgence exposes fragile immunity amid waning vaccine confidence

Decades of progress in controlling measles are under threat as declining vaccination coverage and growing distrust threaten to undo recent gains, prompting urgent calls for renewed public health efforts worldwide.

The measles defences built over the past six decades are starting to look alarmingly brittle. A disease once pushed to the margins by routine vaccination is returning with force in several parts of the world, driven not by a more dangerous virus but by falling immunisation rates and growing doubt about vaccines. The scale of the problem is sobering: the World Health Organization says 2024 global measles coverage improved only slightly from the year before, while still falling short of the level needed to stop outbreaks, and the number of countries seeing large or disruptive measles outbreaks rose sharply.

That is the central warning in the Kathimerini opinion piece by Athanasios Tsakris, who points out that measles remains one of the most contagious infections known. A single case can spread widely among the unvaccinated, and the disease still causes severe complications, particularly in young children, pregnant women, adults over 20 and people with weakened immune systems. Tsakris notes that vaccination has prevented tens of millions of deaths since the first measles shots were licensed in the United States in 1963 and the combined MMR vaccine followed in 1971.

Yet the protection is weakening. Data from the World Health Organization and UNICEF show that in 2024 only 89% of infants worldwide received at least one dose of a diphtheria, tetanus and pertussis-containing vaccine, while 85% completed the full three-dose series. For measles control, the threshold is not simply high coverage but near-universal coverage: public health agencies say around 95% protection is needed in each community to stop sustained spread. The WHO warns that fragile, conflict-affected and vulnerable areas continue to account for a disproportionate share of unvaccinated children.

The global picture is reflected in current outbreaks. Tsakris cites a serious resurgence in Bangladesh, where health officials have linked the problem to gaps in childhood immunisation and weak health services. The World Health Organization and UNICEF have also reported that measles outbreaks increased across the world in 2024, with dozens of countries affected. The pattern is consistent: where vaccine uptake slips, the virus finds room to move again.

The Americas are showing the same vulnerability. According to the Kathimerini piece, by early September confirmed cases had passed 52,000 across 17 countries, led by Guatemala, Mexico, Peru and Canada. In the United States, the numbers are especially stark. USAFacts, drawing on federal data, says 3,471 cases had been confirmed by 17 September 2026, making it the country’s highest annual count since measles was declared eliminated in 2000. The same source says 9% of patients required hospitalisation, and the Centres for Disease Control and Prevention is investigating four deaths reported in Pennsylvania. A separate review published in the medical literature says the country’s 2025 resurgence had already shown how quickly measles can rebound when vaccination levels slip, with outbreaks spread across many states and most patients unvaccinated or of unknown status.

The American debate has also become political. Tsakris notes that public confidence in childhood vaccines has fallen, and that the country’s kindergarten vaccination coverage has dipped below the level needed to halt transmission. He also points to the messages of Robert F. Kennedy Jr, the US health secretary under Donald Trump, who has repeatedly downplayed measles and questioned established vaccine policy while promoting unproven approaches such as vitamin A and fish oil. The broader concern is not only the disease itself, but the erosion of trust that once made elimination possible.

That erosion is now being felt in Europe as well, though the picture is less severe. The WHO says measles cases fell in 2025 compared with 2024, but transmission continues in under-vaccinated communities and the situation remains fragile. In Greece, the article says, first-dose childhood coverage has fallen from 97% in 2019 to 91% in 2024, while second-dose coverage has dropped from 76% to 71%. That matters because measles is not a harmless childhood illness. It can cause seizures, blindness, deafness, lung damage and, in rare cases, subacute sclerosing panencephalitis, a fatal neurological disorder that may appear years after infection. The virus can also weaken the immune system’s memory, leaving people more vulnerable to other infections long after they recover.

The larger lesson is that measles has not changed; our collective protection has. Bill Gates has argued that global eradication now looks out of reach because vaccine hesitancy is spreading even in wealthy countries. That is not a reason for defeatism, but it is a reminder that science alone is not enough. The vaccine works. The question is whether enough parents, patients and governments still believe in it to keep the wall standing.

Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.